Financial News
Articles published by Gamida Cell Ltd.
Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
October 16, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell Issues Update on Israel Operations
October 09, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa
October 02, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
September 28, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv)
September 27, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell to Present Corporate Highlights at the H.C. Wainwright 25th Annual Global Investment Conference
August 31, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update
August 14, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell to Report Second Quarter 2023 Financial Results
August 01, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell Appoints Terry Coelho as CFO
May 22, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
April 17, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell Announces Changes to Board of Directors
March 20, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell Announces the Date of Its Fourth Quarter and Full Year 2022 Financial Results and Webcast
March 20, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell to Present Corporate Highlights at the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTR
February 18, 2023
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell Announces Closing of $25 Million Financing With Highbridge
December 12, 2022
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences
November 23, 2022
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell Provides Regulatory Update on Omidubicel
November 21, 2022
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update
November 14, 2022
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell to Present Corporate Highlights at the Jefferies London Healthcare Conference
November 10, 2022
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
GDA-501, NAM enabled NK Cell Therapy, Demonstrates Promising Antitumor Activity Against HER2+ Cancers
November 07, 2022
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell Announces the Date of Its Third Quarter 2022 Financial Results and Webcast
November 07, 2022
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Gamida Cell Announces Omidubicel Data To Be Presented as an Oral Presentation at 64th ASH Annual Meeting
November 03, 2022
From Gamida Cell Ltd.
Via Business Wire
Tickers
GMDA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.